Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhang, Jianping
NCT06552520: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis	Not yet recruiting	3	500	RoW	TQH2722 injection, Placebo of TQH2722 injection	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.	Atopic Dermatitis	10/25	06/26
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis	Recruiting	2	129	RoW	ICP-488 Tablets, ICP-488 Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Moderate to Severe Plaque Psoriasis	10/24	11/24